Acitretin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Acitretin.
Product ID | 0093-1138_088a7c92-0c85-4761-b0f9-9766f9f272a7 |
NDC | 0093-1138 |
Product Type | Human Prescription Drug |
Proprietary Name | Acitretin |
Generic Name | Acitretin |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2013-07-19 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA202897 |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Substance Name | ACITRETIN |
Active Ingredient Strength | 18 mg/1 |
Pharm Classes | Retinoid [EPC],Retinoids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2013-07-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA202897 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-07-19 |
Ingredient | Strength |
---|---|
ACITRETIN | 17.5 mg/1 |
SPL SET ID: | 993a5325-cd10-4450-b5ea-1c0a90510df6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0093-1135 | Acitretin | Acitretin |
0093-1136 | Acitretin | Acitretin |
0093-1138 | Acitretin | Acitretin |
0115-1667 | Acitretin | Acitretin |
0115-1668 | Acitretin | Acitretin |
0115-1669 | Acitretin | Acitretin |
0115-1698 | Acitretin | Acitretin |
0115-1750 | Acitretin | Acitretin |
0115-1751 | Acitretin | Acitretin |
0115-1752 | Acitretin | Acitretin |
0115-1753 | Acitretin | Acitretin |
42291-086 | ACITRETIN | ACITRETIN |
42291-087 | ACITRETIN | ACITRETIN |
42291-088 | ACITRETIN | ACITRETIN |
42794-081 | ACITRETIN | ACITRETIN |
42794-080 | ACITRETIN | ACITRETIN |
42794-083 | ACITRETIN | ACITRETIN |
0378-7023 | Acitretin | Acitretin |
0378-7020 | Acitretin | Acitretin |
66993-896 | ACITRETIN | ACITRETIN |
66993-894 | ACITRETIN | ACITRETIN |
0145-0090 | SORIATANE | acitretin |
0145-0091 | SORIATANE | acitretin |